Aarhus University Seal / Aarhus Universitets segl

Apolipoprotein M and Risk of Type 2 Diabetes

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Stefan Hajny, Københavns Universitet
  • ,
  • Mette Christoffersen, Københavns Universitet
  • ,
  • Nawar Dalila, Københavns Universitet
  • ,
  • Lars B. Nielsen
  • ,
  • Anne Tybjærg-Hansen, Københavns Universitet
  • ,
  • Christina Christoffersen, Københavns Universitet

Context: Recent studies have discovered a role of apolipoprotein M (apoM) in energy metabolism, and observational analyses in humans suggest an association with type 2 diabetes. The causal relationship remains however elusive. Objective: To investigate whether reduced plasma apoM concentrations are causally linked to increased risk of type 2 diabetes. Design: Prospective study design analyzed by Mendelian randomization. Setting and participants: Two cohorts reflecting the Danish general population: the Copenhagen City Heart Study (CCHS, n = 8589) and the Copenhagen General Population Study (CGPS; n = 93 857). Observational analyses included a subset of participants from the CCHS with available plasma apoM (n = 725). Genetic analyses included the complete cohorts (n = 102 446). During a median follow-up of 16 years (CCHS) and 8 years (CGPS), 563 and 2132 participants developed type 2 diabetes. Main outcome measures: Plasma apoM concentration, genetic variants in APOM, and type 2 diabetes. Results: First, we identified an inverse correlation between plasma apoM and risk of type 2 diabetes in a subset of participants from the CCHS (hazard ratio between highest vs lowest quartile (reference) = 0.32; 95% confidence interval = 0.1-1.01; P for trend = .02). Second, genotyping of specific single nucleotide polymorphisms in APOM further revealed a 10.8% (P = 6.2 × 10–5) reduced plasma apoM concentration in participants with variant rs1266078. Third, a meta-analysis including data from 599 451 individuals showed no association between rs1266078 and risk of type 2 diabetes. Conclusions: The present study does not appear to support a causal association between plasma apoM and risk of type 2 diabetes.

OriginalsprogEngelsk
TidsskriftJournal of Clinical Endocrinology and Metabolism
Vol/bind105
Nummer9
Sider (fra-til)3046-3057
Antal sider12
ISSN0021-972X
DOI
StatusUdgivet - sep. 2020

Bibliografisk note

Funding Information:
This research was funded by the Novo Nordisk Fonden (Grant No. NNF13OC0003898) and Danmarks Frie Forskningsr?d (Grant No. 1331-00337B).

Publisher Copyright:
© endocrine society 2020. all rights reserved.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Se relationer på Aarhus Universitet Citationsformater

ID: 217224463